Abstract
Cationic liposomes based on the cationic lipid 1,26-bis(cholest-5-en-3β-yloxycarbonylamino)- 7,11,16-2-tetraazahexacosane tetrahydrochloride (2X3) and the helper lipid 1,2-dioleoyl-sn-glycero-3-phosphatidylethanolamine (DOPE) have been prepared by two methods, namely ultrasonication and the extrusion of a lipid dispersion. The effect of the preparation method and the type of the water phase on the physicochemical characteristics of cationic liposomes and their biological activity has been studied. The optimization of the preparation of cationic liposomes made it possible to determine the technological parameters providing the reproducibility of physicochemical characteristics of liposomes from batch to batch.
Similar content being viewed by others
Abbreviations
- 2Х3:
-
1,26-bis(cholest-5-en-3β-yloxycarbonylamino)- 7,11,16-2-tetraazahexacosane tetrahydrochloride
- DOPE:
-
1,2-dioleoyl-sn-glycero-3-phosphatidylethanolamine
- EGFP:
-
enhanced green fluorescent protein
- FBS:
-
fetal bovine serum
- PBS:
-
phosphate-buffered saline, pH 7.6
- siRNA:
-
small interfering RNA
- ODN:
-
oligodeoxyribonucleotide
- pDNA:
-
plasmid DNA
- PAG:
-
polyacrylamide gel
References
Jellema, R.K., Bomans, P., Deckers, N., Ungethum, L., Reutelingsperger, C.P.M., Hofstra, L., and Frederik, P.M., J. Lipos. Res., 2010, vol. 20, pp. 258–267.
Wang, Y., Miao, L., Satterlee, A., and Huang, L., Adv. Drug Deliv. Rev., 2015, vol. 87, pp. 68–80.
Godbey, W.T. and Mikos, A.G., J. Control. Release, 2001, vol. 72, pp. 115–125.
Torchilin, V.P., Nature Rev., 2005, vol. 4, pp. 145–160.
Ju, J., Huan, M.-L., Wana, N., Hou, Y.-L., Maa, X.-X., Jia, Y.-Y., Li, C., Zhou, S.-Y., and Zhang, B.-L., Bioorg. Med. Chem., 2016, vol. 26, pp. 2401–2407.
Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S.-W., and Zarghami, N., Nanoscale Res. Lett., 2013, vol. 8, p. 102.
Tarahovsky, Y.S., Biochemistry, 2009, vol. 74, pp. 1293–1304.
Petros, R.A. and DeSimone, J.M., Nat. Rev. Drug Discov., 2010, vol. 9, pp. 615–627.
Verma, A. and Stellacci, F., Nanomater.–Cell Interact., 2010, vol. 6, pp. 12–21.
Cullis, P.R. and Kruijff, B.D., Biochim. Biophys. Acta, 1979, vol. 559, pp. 399–420.
Farhood, H., Serbina, N., and Huang, L., Biochim. Biophys. Acta, 1995, vol. 1235, pp. 289–295.
Hafez, I.M. and Cullis, P.R., Adv. Drug Deliv. Rev., 2001, vol. 47, pp. 139–148.
Hafez, I.M., Maurer, N., and Cullis, P.R., Gene Ther., 2001, vol. 8, pp. 1188–1196.
Koltover, I., Science, 1998, vol. 281, pp. 78–81.
Richardson, E.S., Woodbury, D.J., and Pitt, W.G., Biophys. J., 2007, vol. 93, pp. 4100–4107.
Cho, N.J., Hwang, L.Y., Solandt, J.J.R., and Frank, C.W., Materials, 2013, vol. 6, pp. 3294–3308.
Jafari, M., Soltani, M., Naahidi, S., Karunaratne, D.N., and Chen, P., Cur. Med. Chem., 2012, vol. 19, pp. 197–208.
Findeis, M.A., Meth. Mol. Med., 2001, pp. 135–136.
Bavykin, A.S., Korotaeva, A.A., Poyarkov, S.V., Syrtsev, A.V., Tjulandin, S.A., and Karpukhin, A.V., Onco Targets Ther., 2013, vol. 6, pp. 1333–1340.
Petukhov, I.A., Maslov, M.A., Morozova, N.G., and Serebrennikova, G.A., Russ. Chem. Bull., 2010, vol. 59, pp. 260–268.
Ui-Tei, K., Naito, Y., Takahashi, F., Haraguchi, T., Ohki-Hamazaki, H., Juni, A., Ueda, R., and Saigo, K., Nucleic Acids Res., 2004, vol. 32, pp. 936–948.
Author information
Authors and Affiliations
Corresponding author
Additional information
Proceedings of the Conference “Lipids of XXI Century. The First Quarter,” Moscow, 22–23 October 2018.
Rights and permissions
About this article
Cite this article
Luneva, A.S., Puchkov, P.A., Shmendel, E.V. et al. Optimization of the Technology for the Preparation of Cationic Liposomes for the Delivery of Nucleic Acids. Russ J Bioorg Chem 44, 724–731 (2018). https://doi.org/10.1134/S1068162019010084
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162019010084